Posted 2/27/2024, 12:22:00 PM
Viking Therapeutics Stock Soars on Positive Weight Loss Drug Trial Results
- Viking Therapeutics stock doubled after positive trial results for its weight-loss drug VK2735
- Drug showed statistically significant weight loss of up to 14.7% from baseline vs 4% for placebo
- Up to 88% of treatment group achieved 10% or more weight loss
- Viking plans to meet with FDA to discuss next steps and further trial details
- Stock has gained 250% in last 12 months on hopes for obesity and NASH treatments